info@seagull-health.com
SeagullHealth
语言:
search
new
Precautions for Using Caplacizumab
504
Article source: Seagull Pharmacy
Aug 25, 2025

Caplacizumab is a specific drug for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults, manufactured by the French company Sanofi. Since this drug has not yet been launched in China, patients need to purchase authentic products through specific channels. Then, what are the precautions for using Caplacizumab?

Precautions for Using Caplacizumab

Standardized medication is crucial for ensuring therapeutic efficacy and reducing risks. As an antiplatelet drug, Caplacizumab requires special medication management.

Pre-Treatment Evaluation

Before using the drug, it is necessary to complete platelet count, ADAMTS13 activity testing, and coagulation function examination.

Assess bleeding risk factors, including a history of previous bleeding, concurrent medications, etc.

Women of childbearing age must confirm that they are not pregnant and need to take reliable contraceptive measures during treatment.

Injection Technique Requirements

The first dose must be administered intravenously by medical staff. Subsequent subcutaneous injections can be given in the abdomen (at least 5 cm away from the umbilicus), thighs, or upper arms.

Allow the drug solution to return to room temperature before injection, and apply pressure to the injection site for 5 minutes after injection.

Rotate injection sites and avoid repeated injections in the same area.

Use a dedicated sharps container to dispose of used needles.

Adverse Reaction Monitoring

Establish a medication diary to record the time, site of each injection, and physical reactions.

Closely monitor for bleeding symptoms; if a nosebleed lasts for more than 10 minutes or hematuria occurs, seek medical attention immediately.

Regularly recheck platelet count and coagulation function, generally 1-2 times a week.

Authentic Purchase Channels for Caplacizumab

Ensuring a formal source of the drug is the primary condition for safe treatment. Caplacizumab is a prescription drug and needs to be obtained through professional medical channels.

Procurement through Cooperation with International Hospitals

Some domestic hospitals have cooperative programs with Sanofi-authorized medical institutions, which can assist patients in purchasing the drug from formal channels in Europe.

Sanofi Officially Authorized Pharmacies

Sanofi has an authorized pharmacy network in various EU countries. Patients can inquire about the nearest authorized pharmacy through the official website.

Cross-Border Medical Service Institutions

Professional cross-border medical intermediaries can assist patients in contacting specialized hospitals in Europe for medical treatment and obtaining prescriptions. This method is suitable for patients who need to adjust their treatment plans; a medical team will follow up throughout the process, and the drug can be purchased directly from the hospital pharmacy.

Dietary Precautions for Caplacizumab

Reasonable dietary management helps reduce the risk of bleeding and improve treatment effects. Special nutritional adjustments are required during the medication period.

Foods Affecting Coagulation

Limit the intake of foods rich in vitamin K (such as spinach, broccoli) to no more than 100 grams per day.

Avoid excessive consumption of condiments that may affect coagulation, such as garlic and ginger.

Control alcohol intake: no more than 2 standard drinks per day for men and no more than 1 standard drink per day for women. (Note: A "standard drink" typically refers to a beverage containing approximately 10-15 grams of pure alcohol, with specific standards varying slightly by region.)

Nutritional Supplement Recommendations

Appropriately increase the intake of foods rich in vitamin C (such as citrus fruits, bell peppers) to enhance blood vessel elasticity.

The daily protein intake should be 1.2-1.5 grams per kilogram of body weight, with priority given to fish, poultry, and soy products.

Maintain daily water intake at 2000-2500 milliliters, distributed evenly throughout the day.

Record daily dietary intake, including the type, quantity of food, and physical reactions.

Conduct regular nutritional assessments and consult a clinical dietitian to adjust the diet plan if necessary.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Caplacizumab(Cablivi)
Caplacizumab(Cablivi)
CABLIVI (caplacizumab-yhdp) is specifically indicated for the treatment of...
WeChat Scan
Free Inquiry
Recommended Articles
Side Effects of Caplacizumab
Caplacizumab is a specific drug for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults.  Since this drug has not yet been launched in China and is not included in the ...
Therapeutic Effects of Caplacizumab
Caplacizumab is an innovative therapeutic drug for acquired thrombotic thrombocytopenic purpura (aTTP) in adults. Its unique nanobody technology platform and significant therapeutic effects have broug...
Latest Price of Caplacizumab in 2025
Caplacizumab is a nanobody drug used for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults, manufactured by Sanofi (France). It has not yet been launched in China and is n...
Dosage and Administration of Caplacizumab (Cablivi)
Caplacizumab must be used in conjunction with plasma exchange and immunosuppressive therapy. Precise timing of medication administration and standardized injection techniques are crucial for ensuring ...
Ambrisentan(Endobloc):Clinical Uses, Recommended Dosage, Treatment Effect
With its unique pharmacological effects, Ambrisentan has brought good news to many patients, helping them alleviate the pain caused by diseases. Just like any other medication, the use of Ambrisentan ...
What Are the Side Effects of Ambrisentan?
Ambrisentan is primarily used for the treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and delay clinical symptoms. Like all medications, Ambrisentan may also cause cert...
What Are the Indications of Ambrisentan?
Ambrisentan is an effective therapeutic drug for pulmonary arterial hypertension (PAH). However, during its use, patients must strictly follow the doctor’s guidance and pay attention to the relevant c...
Precautions for Ambrisentan
As an important drug for the treatment of pulmonary arterial hypertension (PAH), during the widespread application of Ambrisentan, we must pay attention to medication issues in special populations. Fo...
Related Articles
Precautions for Using Caplacizumab
Caplacizumab is a specific drug for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults, manufactured by the French company Sanofi. Since this drug has not yet been launched...
Side Effects of Caplacizumab
Caplacizumab is a specific drug for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults.  Since this drug has not yet been launched in China and is not included in the ...
Therapeutic Effects of Caplacizumab
Caplacizumab is an innovative therapeutic drug for acquired thrombotic thrombocytopenic purpura (aTTP) in adults. Its unique nanobody technology platform and significant therapeutic effects have broug...
Latest Price of Caplacizumab in 2025
Caplacizumab is a nanobody drug used for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults, manufactured by Sanofi (France). It has not yet been launched in China and is n...
Dosage and Administration of Caplacizumab (Cablivi)
Caplacizumab must be used in conjunction with plasma exchange and immunosuppressive therapy. Precise timing of medication administration and standardized injection techniques are crucial for ensuring ...
Caplacizumab (Cablivi):Clinical Uses, Recommended Dosage, Treatment Effect
Caplacizumab (Cablivi) is a targeted therapeutic agent classified as a monoclonal antibody fragment (nanobody), primarily indicated for the treatment of adult acquired thrombotic thrombocytopenic purp...
Effects and efficacy of Caplacizumab
Caplacizumab is a drug specifically used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in adults. This article will explore its effects and efficacy, possible adverse reactions, an...
Instructions for Caplacizumab: Precautions, Actions and Efficacy, Usage and Dosage, Side Effects
Caplacizumab is a nano-antibody drug used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in adults. It reduces platelet consumption by blocking the interaction between von Willebran...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved